• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由Vpu介导的HIV-1病毒颗粒释放不同于由p6介导的释放。

HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.

作者信息

Schwartz M D, Geraghty R J, Panganiban A T

机构信息

McArdle Laboratory for Cancer Research, University of Wisconsin, Medical School, Madison 53706, USA.

出版信息

Virology. 1996 Oct 1;224(1):302-9. doi: 10.1006/viro.1996.0532.

DOI:10.1006/viro.1996.0532
PMID:8862425
Abstract

Vpu and the C-terminal peptide of Gag (p6) are both HIV-1-encoded proteins that augment the release of virus particles from cells. We examined the functional relationship between these proteins and their activities during particle release. Our results indicate that efficient HIV-1 particle release from HeLa and Jurkat cells depends on the presence of Vpu. However, Vpu is dispensable for efficient release from Cos cells. In contrast, p6 is required for efficient release from Cos cells but not from Jurkat or HeLa cells. These data suggest that Vpu and p6 have distinct activities in virus exit from different cell lines. Intracellular proteolytic processing of Gag precursor protein is more complete in Cos cells than in HeLa cells. However, this processing has little or no effect on Vpu- or p6-mediated particle release. p6 is required for incorporation of yet another virus protein (Vpr) into cells but our data suggest that Vpr plays no role in p6-dependent particle release. Vpu also facilitates the degradation of CD4 in virus producing cells but, in contrast to particle release, the ability of Vpu to facilitate the degradation of CD4 is not cell line-dependent.

摘要

Vpu和Gag的C末端肽(p6)都是HIV-1编码的蛋白质,它们可增强病毒颗粒从细胞中的释放。我们研究了这些蛋白质之间的功能关系及其在颗粒释放过程中的活性。我们的结果表明,从HeLa细胞和Jurkat细胞中有效释放HIV-1颗粒取决于Vpu的存在。然而,Vpu对于从Cos细胞中有效释放是可有可无的。相反,p6是从Cos细胞中有效释放所必需的,但从Jurkat细胞或HeLa细胞中释放则不需要。这些数据表明,Vpu和p6在病毒从不同细胞系中释放时具有不同的活性。Gag前体蛋白在Cos细胞中的细胞内蛋白水解加工比在HeLa细胞中更完整。然而,这种加工对Vpu或p6介导的颗粒释放几乎没有影响。p6是另一种病毒蛋白(Vpr)掺入细胞所必需的,但我们的数据表明Vpr在p6依赖性颗粒释放中不起作用。Vpu还促进病毒产生细胞中CD4的降解,但与颗粒释放相反,Vpu促进CD4降解的能力不依赖于细胞系。

相似文献

1
HIV-1 particle release mediated by Vpu is distinct from that mediated by p6.由Vpu介导的HIV-1病毒颗粒释放不同于由p6介导的释放。
Virology. 1996 Oct 1;224(1):302-9. doi: 10.1006/viro.1996.0532.
2
The HIV-1 matrix domain of Gag is required for Vpu responsiveness during particle release.在病毒粒子释放过程中,Vpu反应需要Gag的HIV-1基质结构域。
Virology. 1997 Oct 13;237(1):46-55. doi: 10.1006/viro.1997.8711.
3
The human immunodeficiency virus type 1 Vpu protein tethered to the CD4 extracellular domain is localized to the plasma membrane and is biologically active in the secretory pathway of mammalian cells: implications for the mechanisms of Vpu function.与CD4细胞外结构域相连的1型人类免疫缺陷病毒Vpu蛋白定位于质膜,且在哺乳动物细胞的分泌途径中具有生物活性:对Vpu功能机制的启示
Virology. 1996 Jun 1;220(1):141-51. doi: 10.1006/viro.1996.0294.
4
The N-terminal matrix domain of HIV-1 Gag is sufficient but not necessary for viral protein U-mediated enhancement of particle release through a membrane-targeting mechanism.HIV-1 Gag的N端基质结构域足以通过膜靶向机制介导病毒蛋白U增强颗粒释放,但并非必需。
Virology. 2000 Apr 10;269(2):305-12. doi: 10.1006/viro.1999.0094.
5
Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein.Vpu结合蛋白与微管的关联以及HIV-1 Gag蛋白的Vpu依赖性重新分布
Virology. 2001 Dec 20;291(2):198-207. doi: 10.1006/viro.2001.1166.
6
Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.Vpr整合入1型人类免疫缺陷病毒:Pr55gag蛋白P6结构域内保守区域的作用
J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 1;10(1):1-7.
7
Structural and functional analysis of the membrane-spanning domain of the human immunodeficiency virus type 1 Vpu protein.1型人类免疫缺陷病毒Vpu蛋白跨膜结构域的结构与功能分析
Virology. 1998 Nov 10;251(1):96-107. doi: 10.1006/viro.1998.9368.
8
Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.将上游vpu序列与猿猴人类免疫缺陷病毒(SHIV(KU-1bMC33))的env融合,会导致合成两种包膜前体蛋白,增加与细胞表面相关的病毒颗粒数量,并且对食蟹猴具有致病性。
Virology. 2004 May 20;323(1):91-107. doi: 10.1016/j.virol.2004.02.028.
9
Tethered virions are intermediates in the assembly and release of HIV-1 particles.有尾病毒是 HIV-1 颗粒组装和释放的中间体。
Virology. 2010 Nov 25;407(2):289-95. doi: 10.1016/j.virol.2010.08.020. Epub 2010 Sep 20.
10
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.束缚素抑制逆转录病毒释放,并被HIV-1 Vpu蛋白拮抗。
Nature. 2008 Jan 24;451(7177):425-30. doi: 10.1038/nature06553. Epub 2008 Jan 16.

引用本文的文献

1
CAML does not modulate tetherin-mediated restriction of HIV-1 particle release.CAML 不会调节 tetherin 介导的 HIV-1 粒子释放限制。
PLoS One. 2010 Feb 2;5(2):e9005. doi: 10.1371/journal.pone.0009005.
2
Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu.鉴定钙调亲环素配体为HIV-1释放的一种人类宿主限制因素,而Vpu可克服这种限制。
Nat Med. 2008 Jun;14(6):641-7. doi: 10.1038/nm1778. Epub 2008 May 25.
3
Recruitment of the adaptor protein 2 complex by the human immunodeficiency virus type 2 envelope protein is necessary for high levels of virus release.
人类免疫缺陷病毒2型包膜蛋白招募衔接蛋白2复合物是高水平病毒释放所必需的。
J Virol. 2006 Mar;80(6):2924-32. doi: 10.1128/JVI.80.6.2924-2932.2006.
4
Ebola virus VP40 late domains are not essential for viral replication in cell culture.埃博拉病毒VP40晚期结构域对于病毒在细胞培养中的复制并非必不可少。
J Virol. 2005 Aug;79(16):10300-7. doi: 10.1128/JVI.79.16.10300-10307.2005.
5
Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.增强病毒产生所需的人类免疫缺陷病毒2型包膜蛋白内的功能域。
J Virol. 2005 Mar;79(6):3627-38. doi: 10.1128/JVI.79.6.3627-3638.2005.
6
The vpu protein of human immunodeficiency virus type 1 plays a protective role against virus-induced apoptosis in primary CD4(+) T lymphocytes.人类免疫缺陷病毒1型的vpu蛋白在原代CD4(+) T淋巴细胞中对病毒诱导的细胞凋亡起保护作用。
J Virol. 2003 Oct;77(19):10304-13. doi: 10.1128/jvi.77.19.10304-10313.2003.
7
Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.马传染性贫血病毒复制中同源和异源L结构域的功能替代及位置依赖性
J Virol. 2002 Feb;76(4):1569-77. doi: 10.1128/jvi.76.4.1569-1577.2002.
8
The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles.含晚期结构域蛋白p6是1型人类免疫缺陷病毒颗粒中的主要磷蛋白。
J Virol. 2002 Feb;76(3):1015-24. doi: 10.1128/jvi.76.3.1015-1024.2002.
9
Functional roles of equine infectious anemia virus Gag p9 in viral budding and infection.马传染性贫血病毒Gag p9在病毒出芽和感染中的功能作用
J Virol. 2001 Oct;75(20):9762-70. doi: 10.1128/JVI.75.20.9762-9770.2001.
10
A lentivirus packaging system based on alternative RNA transport mechanisms to express helper and gene transfer vector RNAs and its use to study the requirement of accessory proteins for particle formation and gene delivery.一种基于替代RNA转运机制的慢病毒包装系统,用于表达辅助RNA和基因转移载体RNA,及其在研究辅助蛋白对病毒颗粒形成和基因递送的需求中的应用。
J Virol. 1999 Nov;73(11):9589-98. doi: 10.1128/JVI.73.11.9589-9598.1999.